- Companies
- Thor Medical
Thor Medical Valuation Multiples
Thor Medical is valued at $202M as of September 2026, a 174.3x revenue multiple. In the last 12 months, Thor Medical revenue was $1M and Thor Medical EBITDA was ($6M).
Thor Medical Overview
About Thor Medical
Thor Medical ASA is a Norway-based biopharmaceutical company. The company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. It uses a proprietary production process that does not involve irradiation or nuclear reactors to produce alpha-emitting materials. These materials are used by radiopharmaceutical companies in the development of cancer therapies.
Founded
2009
HQ
Employees
18
Website
Financials (LTM)
EV
$222M
Valuation Multiples
Start free trialThor Medical Financials
Thor Medical reported last 12-month revenue of $1M and negative EBITDA of ($6M).
In the same LTM period, Thor Medical generated $527K in gross profit, ($6M) in EBITDA losses, and had net loss of ($8M).
Revenue (LTM)
Thor Medical P&L
In the most recent fiscal year, Thor Medical reported revenue of $46K and EBITDA of ($5M).
Thor Medical is unprofitable as of last fiscal year, with gross margin of 100%, EBITDA margin of (10790%), and net margin of (13215%).
Financial data powered by Morningstar, Inc.
Thor Medical Stock Performance
Thor Medical has current market cap of $202M, and enterprise value of $222M.
Market Cap Evolution
Thor Medical's stock price is $0.48.
Thor Medical share price decreased by 20.3% in the last 30 days, and increased by 38.5% in the last year.
Thor Medical has an EPS (earnings per share) of $-0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $222M | $202M | -1.2% | -20.3% | 5.9% | 38.5% | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialThor Medical Valuation Multiples
Thor Medical trades at 174.3x EV/Revenue multiple, and (36.8x) EV/EBITDA.
EV / Revenue (LTM)
Thor Medical Financial Valuation Multiples
As of September 26, 2026, Thor Medical has market cap of $202M and EV of $222M.
Thor Medical has a P/E ratio of (26.4x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Thor Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Thor Medical Margins & Growth Rates
Thor Medical grew revenue by 3551% and EBITDA by 27% in the last fiscal year.
In the most recent fiscal year, Thor Medical reported gross margin of 100%, EBITDA margin of (10790%), and net margin of (13215%).
Thor Medical Margins
Thor Medical Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Thor Medical Operational KPIs
Thor Medical's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.4M for the same period.
Thor Medical's Rule of 40 is 3176% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Thor Medical's Rule of X is 8503% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Thor Medical Competitors
Thor Medical competitors include Savior Lifetec, TYK Medicines, Nkarta, Compass Therapeutics, Adagene, Medeze Group, Veraxa Biotech, Oramed Pharmaceuticals, Sol-Gel Technologies and Protara Therapeutics.
Most Thor Medical public comparables operate across Biopharmaceuticals, Contract Research & Manufacturing, BioTech, HealthTech and DeepTech.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $38M | $18M | 3.3x | - | 6.8x | - | |||
| - | ($40M) | - | - | (4.9x) | - | |||
| - | ($110M) | - | - | (0.9x) | - | |||
| - | ($73M) | - | - | (0.5x) | (0.4x) | |||
| $8M | ($19M) | 12.4x | 17.6x | (4.9x) | (3.2x) | |||
| $22M | $7M | 6.9x | 6.8x | 20.8x | 18.9x | |||
| $28K | ($79M) | 7064.9x | - | (2.5x) | - | |||
| $2M | ($8M) | 74.7x | 284.0x | (18.6x) | - | |||
This data is available for Pro users. Sign up to see all Thor Medical competitors and their valuation data. Start Free Trial | ||||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Thor Medical
| When was Thor Medical founded? | Thor Medical was founded in 2009. |
| Where is Thor Medical headquartered? | Thor Medical is headquartered in Norway. |
| How many employees does Thor Medical have? | As of today, Thor Medical has over 18 employees. |
| Who is the CEO of Thor Medical? | Thor Medical's CEO is Jasper Kurth. |
| Is Thor Medical publicly listed? | Yes, Thor Medical is a public company listed on Oslo Børs. |
| What is the stock symbol of Thor Medical? | Thor Medical trades under TRMED ticker. |
| When did Thor Medical go public? | Thor Medical went public in 2015. |
| Who are competitors of Thor Medical? | Thor Medical main competitors include Savior Lifetec, TYK Medicines, Nkarta, Compass Therapeutics, Adagene, Medeze Group, Veraxa Biotech, Oramed Pharmaceuticals, Sol-Gel Technologies, Protara Therapeutics. |
| What is the current market cap of Thor Medical? | Thor Medical's current market cap is $202M. |
| What is the current revenue of Thor Medical? | Thor Medical's last 12 months revenue is $1M. |
| What is the current revenue growth of Thor Medical? | Thor Medical revenue growth (NTM/LTM) is 634%. |
| What is the current EV/Revenue multiple of Thor Medical? | Current revenue multiple of Thor Medical is 174.3x. |
| Is Thor Medical profitable? | No, Thor Medical is not profitable. |
| What is the current EBITDA of Thor Medical? | Thor Medical has negative EBITDA and is not profitable. |
| What is Thor Medical's EBITDA margin? | Thor Medical's last 12 months EBITDA margin is (473%). |
| What is the current EV/EBITDA multiple of Thor Medical? | Current EBITDA multiple of Thor Medical is (36.8x). |
| What is the current FCF of Thor Medical? | Thor Medical's last 12 months FCF is ($16M). |
| What is Thor Medical's FCF margin? | Thor Medical's last 12 months FCF margin is (1290%). |
| What is the current EV/FCF multiple of Thor Medical? | Current FCF multiple of Thor Medical is (13.5x). |
| How many companies Thor Medical has acquired to date? | Thor Medical hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Thor Medical has invested to date? | Thor Medical hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Thor Medical
Lists including Thor Medical
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




